Bailey Megan D. 4
4 · LABCORP HOLDINGS INC. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Labcorp EVP Megan Bailey Exercises RSUs; Shares Withheld
What Happened
- Megan D. Bailey, EVP and President, Central Labs & International at Labcorp Holdings (LH), had restricted stock units (RSUs) vest and converted into common stock on Feb 6–7, 2026. A total of 469 RSUs were settled into shares (180 on Feb 6; 222 and 67 on Feb 7). To satisfy tax withholding obligations, 180 shares were withheld (72 on Feb 6; 85 and 23 on Feb 9) for a total tax-withholding value of $49,551. Net shares received after withholding: 289.
Key Details
- Transaction dates and amounts:
- 2026-02-06: 180 RSUs converted to 180 shares; 72 shares withheld at $277.20 = $19,958 (tax withholding).
- 2026-02-07: 222 and 67 RSUs converted to 289 shares total.
- 2026-02-09: 85 shares withheld at $274.01 = $23,291 and 23 shares withheld at $274.01 = $6,302 (tax withholding).
- Total RSUs converted: 469. Total shares withheld for taxes: 180. Net shares delivered to insider: 289.
- Total cash value withheld for taxes: $49,551.
- Footnotes: F1 = each RSU converts to one share; F2 = stock withholding used to satisfy tax obligations; F3/F5 note the applicable vesting schedules for the grants; F4 references aggregate RSUs held (number not shown in this extract).
- Filing: Report filed 2026-02-10 covering transactions dated 2026-02-06 to 2026-02-09 — appears timely (no late filing noted).
Context
- These were RSU settlements (derivative conversion), not open-market sales or purchases. The withholding of shares to cover taxes is routine (a cashless/stock-withholding settlement) and does not necessarily signal a buy or sell decision by the insider.
- For retail investors: RSU vesting is a common form of compensation; such filings are primarily administrative (vesting + tax withholding) unless accompanied by open-market trades.
Insider Transaction Report
Form 4
Bailey Megan D.
EVP, Pres, Central Labs & Intl
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-06+180→ 3,774 total - Tax Payment
Common Stock
[F2]2026-02-06$277.20/sh−72$19,958→ 3,702 total - Exercise/Conversion
Common Stock
[F1]2026-02-07+222→ 3,924 total - Exercise/Conversion
Common Stock
[F1]2026-02-07+67→ 3,991 total - Tax Payment
Common Stock
[F2]2026-02-09$274.01/sh−85$23,291→ 3,906 total - Tax Payment
Common Stock
[F2]2026-02-09$274.01/sh−23$6,302→ 3,883 total - Exercise/Conversion
Restricted Stock Unit
[F1][F3][F4]2026-02-06−180→ 2,419 total→ Common Stock (180 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F5][F4]2026-02-07−222→ 2,197 total→ Common Stock (222 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F5][F4]2026-02-07−67→ 2,130 total→ Common Stock (67 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
- [F4]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F5]The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Megan D. Bailey|2026-02-10